U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Benign Phosphaturic Mesenchymal Tumor

MedGen UID:
819091
•Concept ID:
C3814879
•
Neoplastic Process
Synonyms: Phosphaturic mesenchymal tumor; Phosphaturic mesenchymal tumor, benign
SNOMED CT: Phosphaturic mesenchymal tumor, benign (703649004); Phosphaturic mesenchymal tumor (703649004)

Definition

A phosphaturic mesenchymal tumor with benign histologic features. It may recur locally but does not metastasize. Complete excision is curative. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVBenign Phosphaturic Mesenchymal Tumor

Professional guidelines

PubMed

The additional value of CT images interpretation in the differential diagnosis of benign vs. malignant primary bone lesions with 18F-FDG-PET/CT.
Strobel K, Exner UE, Stumpe KD, Hany TF, Bode B, Mende K, Veit-Haibach P, von Schulthess GK, Hodler J
Eur J Nucl Med Mol Imaging 2008 Nov;35(11):2000-8. Epub 2008 Aug 20 doi: 10.1007/s00259-008-0876-0. PMID: 18712385

Recent clinical studies

Etiology

Surgical Treatments of Tumor-Induced Osteomalacia Lesions in Long Bones: Seventeen Cases with More Than One Year of Follow-up.
Wang H, Zhong D, Liu Y, Jiang Y, Qiu G, Weng X, Xing X, Li M, Meng X, Li F, Zhu Z, Yu W, Xia W, Jin J
J Bone Joint Surg Am 2015 Jul 1;97(13):1084-94. doi: 10.2106/JBJS.N.01299. PMID: 26135075
Persistent tumor-induced osteomalacia confirmed by elevated postoperative levels of serum fibroblast growth factor-23 and 5-year follow-up of bone density changes.
Zimering MB, Caldarella FA, White KE, Econs MJ
Endocr Pract 2005 Mar-Apr;11(2):108-14. doi: 10.4158/EP.11.2.108. PMID: 15901526

Diagnosis

Surgical Treatments of Tumor-Induced Osteomalacia Lesions in Long Bones: Seventeen Cases with More Than One Year of Follow-up.
Wang H, Zhong D, Liu Y, Jiang Y, Qiu G, Weng X, Xing X, Li M, Meng X, Li F, Zhu Z, Yu W, Xia W, Jin J
J Bone Joint Surg Am 2015 Jul 1;97(13):1084-94. doi: 10.2106/JBJS.N.01299. PMID: 26135075
Tumor-induced osteomalacia: benign tumor recurrence after two surgical resections at two different medical institutions.
Yasuda S, Wada S, Kono S, Miyajima T, Oda H, Katayama S, Awata T
Endocr Pract 2013 Jul-Aug;19(4):e97-101. doi: 10.4158/EP13042.CR. PMID: 23512396

Prognosis

Surgical Treatments of Tumor-Induced Osteomalacia Lesions in Long Bones: Seventeen Cases with More Than One Year of Follow-up.
Wang H, Zhong D, Liu Y, Jiang Y, Qiu G, Weng X, Xing X, Li M, Meng X, Li F, Zhu Z, Yu W, Xia W, Jin J
J Bone Joint Surg Am 2015 Jul 1;97(13):1084-94. doi: 10.2106/JBJS.N.01299. PMID: 26135075
Persistent tumor-induced osteomalacia confirmed by elevated postoperative levels of serum fibroblast growth factor-23 and 5-year follow-up of bone density changes.
Zimering MB, Caldarella FA, White KE, Econs MJ
Endocr Pract 2005 Mar-Apr;11(2):108-14. doi: 10.4158/EP.11.2.108. PMID: 15901526

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...